0001615219-14-000001.txt : 20140806 0001615219-14-000001.hdr.sgml : 20140806 20140806171154 ACCESSION NUMBER: 0001615219-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140806 DATE AS OF CHANGE: 20140806 EFFECTIVENESS DATE: 20140806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Flex Pharma, Inc. CENTRAL INDEX KEY: 0001615219 IRS NUMBER: 465087339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-222417 FILM NUMBER: 141020820 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET STREET 2: 24TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-874-1821 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET STREET 2: 24TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 D 1 primary_doc.xml X0707 D LIVE 0001615219 Flex Pharma, Inc. 800 BOYLSTON STREET 24TH FLOOR BOSTON MA MASSACHUSETTS 02199 617-874-1821 DELAWARE None None Corporation true 2014 Christoph Westphal c/o Flex Pharma, Inc. 800 Boylston Street, 24th Floor Boston MA MASSACHUSETTS 02199 Executive Officer Director Peter Barton Hutt c/o Flex Pharma, Inc. 800 Boylston Street, 24th Floor Boston MA MASSACHUSETTS 02199 Director Stephen Kraus c/o Flex Pharma, Inc. 800 Boylston Street, 24th Floor Boston MA MASSACHUSETTS 02199 Director Biotechnology Decline to Disclose 06b false 2014-07-23 false true false 0 22000000 16224982 5775018 false 20 0 0 0 false Flex Pharma, Inc. /s/ Christoph Westphal Christoph Westphal President & CEO 2014-08-06